Edding
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A biotech developing novel antibody therapies for oncology and immunology.
OncologyImmunology
Technology Platform
Antibody discovery and engineering platform for developing monoclonal and bispecific antibodies.
Opportunities
Growing global and domestic demand for targeted biologics in autoimmune and cancer treatment.
Risk Factors
High technical and clinical development risk associated with novel antibody constructs.
Competitive Landscape
Operates in a highly innovative but crowded segment of Chinese biotech focused on antibody therapeutics.